Occidental announced an offer to exercise its outstanding publicly traded warrants at a temporarily reduced price. The Offer is available to ...

The resale of the shares of common stock issuable upon exercise of the existing warrants is registered pursuant to an effective registration statement on Form S-1 (File No. 333-280326).

Roth Capital Partners is acting as the Company's financial advisor for this transaction.

Occidental offers warrant holders a temporary reduced exercise price of $21.30 for their shares until March 31, 2025. Occidental announced an offer to exercise its publicly traded warrants at a ...

This amendment to the Warrant Agreement, initiated on March 3, 2025, lowers the exercise price from $22.00 to $21.30 per share of common stock. The revised terms are part of the Offer to Exercise ...

and no new warrants were issued by the Company as a result of the exercises. The proceeds from the exercise of the warrants will be used for general working capital purposes, including Firefly’s ...

PMGC Holdings Inc. (NASDAQ: ELAB) (“PMGC” or the “Company”) today announced that it will effect a 1-for-7 reverse stock split ...

Organovo is a clinical stage biotechnology company that is developing drugs that are demonstrated to be effective in three-dimensional (3D) human tissues as candidates for drug development. The ...

HOUSTON, March 03, 2025 (GLOBE NEWSWIRE) -- Occidental (NYSE: OXY) today announced an offer to exercise its outstanding publicly traded warrants (the “Warrants”) at a temporarily reduced price ...